Both the FDA and Novo Nordisk are advising patients and providers to check their supplies of Ozempic for counterfeit product. Individuals in possession of a counterfeit product are urged to call Novo ...

Then I will share how we are leveraging the RaniPill technology to develop the next-generation of obesity therapies including our RT-114 and semaglutide ... and dosing size and frequency similar ...

Wondering, “What can I get instead of Ozempic?” A popular replacement is generic semaglutide—which is exactly the same ingredient as Ozempic—but is usually more affordable. Another possible substitute ...

Researchers saw no benefits in terms of weight loss, diabetes remission, or surgery safety when patients received neoadjuvant semaglutide before MBS. HealthDay News — Neoadjuvant semaglutide before ...

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list. Hundreds of ...

NPM-139 treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration with expected once or twice-yearly dosing NPM-139 is a miniature ... its subdermal semaglutide ...

NPM-139 treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration with expected once or twice-yearly dosing NPM ... its subdermal semaglutide implant under ...

NPM-139 treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration with expected once or twice-yearly dosing NPM ... containing semaglutide generated $25 billion ...

ALAMEDA, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical ...

NanoPortal™ technology successfully delivers semaglutide, the active ingredient ... administration with expected once or twice-yearly dosing NPM-139 is a miniature, subdermal implant in ...